Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Fluicell | FLUI | 10. jui 2024 | 0.09 | -5.57 |
Gabather | GABA | 10. jui 2024 | 1.70 | -6.61 |
Genovis | GENO | 10. jui 2024 | 34.10 | -3.94 |
Glycorex Transplantati.. | GTABB | 10. jui 2024 | 0.91 | -6.75 |
Guard Therapeutics International | GUARD | 10. jui 2024 | 35.60 | -2.20 |
Hamlet BioPharma AB (publ) | HAMLETB | 10. jui 2024 | 4.88 | +1.67 |
Hansa Biopharma | HNSA | 10. jui 2024 | 52.45 | +2.54 |
Hemply Balance | HMPLY | 10. jui 2024 | 0.03 | +3.33 |
I-tech | ITECH | 10. jui 2024 | 46.00 | +9.00 |
Immunovia | IMMNOV | 10. jui 2024 | 1.68 | +15.43 |
InDex Pharmaceuticals Holding | INDEX | 10. jui 2024 | 0.55 | +1.49 |
Infant Bacterial Therapeutics B | IBTB | 10. jui 2024 | 99.80 | -0.20 |
Initiator Pharma | INIT | 10. jui 2024 | 10.20 | +0.99 |
Intervacc | IVACC | 10. jui 2024 | 3.34 | -2.34 |
IRLAB Therapeutics A | IRLABA | 10. jui 2024 | 13.95 | -1.41 |
Isofol Medical | ISOFOL | 10. jui 2024 | 0.72 | -0.28 |
Kancera | KAN | 10. jui 2024 | 1.82 | +4.96 |
Klaria Pharma Holding | KLAR | 10. jui 2024 | 0.36 | -9.50 |
LIDDS | LIDDS | 10. jui 2024 | 0.15 | +6.52 |
Lipidor | LIPI | 10. jui 2024 | 0.17 | +44.63 |
Lipigon Pharmaceuticals | LPGO | 10. jui 2024 | 0.27 | -4.48 |
Lipum | LIPUM | 10. jui 2024 | 7.75 | +1.97 |
Lumito | LUMITO | 10. jui 2024 | 0.99 | +9.89 |
Magle Chemoswed | MAGLE | 10. jui 2024 | 34.40 | +0.58 |
Medivir | MVIR | 10. jui 2024 | 3.10 | -3.43 |
Mendus AB | IMMU | 10. jui 2024 | 9.59 | -1.94 |
Miris Holding | MIR | 10. jui 2024 | 0.11 | -3.67 |
Moberg Pharma | MOB | 10. jui 2024 | 25.24 | +0.96 |
Modus Therapeutics | MODTX | 10. jui 2024 | 1.04 | -3.24 |
Nanexa | NANEXA | 10. jui 2024 | 0.92 | +1.10 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.